Brief: Axim Biotechnologies Inc Says Filed A Provisional Patent For A First-In-Class Face Mask That Captures And Deactivates Sars-Cov-2
29/09/2020 14:49
Sept 29 (Reuters) - Axim Biotechnologies Inc AXIM.PK :
* AXIM BIOTECHNOLOGIES INC - FILED A PROVISIONAL PATENT FOR
A
FIRST-IN-CLASS FACE MASK THAT CAPTURES AND DEACTIVATES
SARS-COV-2
Source text for Eikon: ID:nGNX9zlzxs
Further company coverage: AXIM.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Axim Biotechnologies
See all newsBrief: AXIM Biotechnologies Partners With Arizona State University To Determine Antibody Levels Against Covid-19
Brief: Axim Biotechnologies Inc Develops Next Generation Of Its Rapid Neutralizing Antibody Test For Covid-19
Brief: AXIM Biotechnologies To Acquire Technology Including
Brief: Axim® Biotechnologies Successfully Completes Point-Of-Care Clinical Trials On Its Rapid Covid-19 Neutralizing Antibody Test
Brief: Axim Biotechnologies Inc Says Filed A Provisional Patent For A First-In-Class Face Mask That Captures And Deactivates Sars-Cov-2